Psychotropic analgesic nitrous oxide for alcohol withdrawal.

Suppr

超能文献

作者信息

Gillman Mark A

出版信息

Am J Health Syst Pharm. 2008 Dec 1;65(23):2205, 2210; author reply 2210. doi: 10.2146/ajhp080268.

DOI:10.2146/ajhp080268

PMID:19020183

Abstract

摘要

相似文献

Psychotropic analgesic nitrous oxide for alcohol withdrawal.

Am J Health Syst Pharm. 2008 Dec 1;65(23):2205, 2210; author reply 2210. doi: 10.2146/ajhp080268.

Correct use of analgesic nitrous oxide for the alcohol withdrawal state is essential.

J Clin Psychopharmacol. 2004 Apr;24(2):238-9; author reply 239-40. doi: 10.1097/01.jcp.0000117433.83724.22.

Randomized double-blind trial of psychotropic analgesic nitrous oxide compared with diazepam for alcohol withdrawal state.

J Subst Abuse Treat. 2002 Apr;22(3):129-34. doi: 10.1016/s0740-5472(02)00224-6.

Enlarged double-blind randomised trial of benzodiazepines against psychotropic analgesic nitrous oxide for alcohol withdrawal.

Addict Behav. 2004 Aug;29(6):1183-7. doi: 10.1016/j.addbeh.2004.03.015.

Psychotropic analgesic nitrous oxide for alcoholic withdrawal states.

Cochrane Database Syst Rev. 2007 Apr 18(2):CD005190. doi: 10.1002/14651858.CD005190.pub2.

Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide in alcohol and drug withdrawal.

Clin Neuropharmacol. 1996 Jun;19(3):246-51. doi: 10.1097/00002826-199619030-00006.

Clinical role and mechanisms of action of analgesic nitrous oxide.

Int J Neurosci. 1998 Feb;93(1-2):55-62. doi: 10.3109/00207459808986412.

Treatment of alcohol withdrawal syndrome with carbamazepine, gabapentin, and nitrous oxide.

Am J Health Syst Pharm. 2008 Jun 1;65(11):1039-47. doi: 10.2146/ajhp070284.

Analgesic nitrous oxide in alcohol withdrawal: the role of melatonin.

Int J Neurosci. 1991 Jan-Feb;56(1-4):201-5, 207-8. doi: 10.3109/00207459108985417.

Analgesic nitrous oxide for alcohol withdrawal is better than placebo.

Int J Neurosci. 1989 Nov;49(1-2):71-4. doi: 10.3109/00207458909087040.

引用本文的文献

Benzodiazepines for alcohol withdrawal.

Cochrane Database Syst Rev. 2010 Mar 17(3):CD005063. doi: 10.1002/14651858.CD005063.pub3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Psychotropic analgesic nitrous oxide for alcohol withdrawal.

Am J Health Syst Pharm. 2008 Dec 1;65(23):2205, 2210; author reply 2210. doi: 10.2146/ajhp080268.

Correct use of analgesic nitrous oxide for the alcohol withdrawal state is essential.

J Clin Psychopharmacol. 2004 Apr;24(2):238-9; author reply 239-40. doi: 10.1097/01.jcp.0000117433.83724.22.

Randomized double-blind trial of psychotropic analgesic nitrous oxide compared with diazepam for alcohol withdrawal state.

J Subst Abuse Treat. 2002 Apr;22(3):129-34. doi: 10.1016/s0740-5472(02)00224-6.

Enlarged double-blind randomised trial of benzodiazepines against psychotropic analgesic nitrous oxide for alcohol withdrawal.

Addict Behav. 2004 Aug;29(6):1183-7. doi: 10.1016/j.addbeh.2004.03.015.

Psychotropic analgesic nitrous oxide for alcoholic withdrawal states.

Cochrane Database Syst Rev. 2007 Apr 18(2):CD005190. doi: 10.1002/14651858.CD005190.pub2.

Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide in alcohol and drug withdrawal.

Clin Neuropharmacol. 1996 Jun;19(3):246-51. doi: 10.1097/00002826-199619030-00006.

Clinical role and mechanisms of action of analgesic nitrous oxide.

Int J Neurosci. 1998 Feb;93(1-2):55-62. doi: 10.3109/00207459808986412.

Treatment of alcohol withdrawal syndrome with carbamazepine, gabapentin, and nitrous oxide.

Am J Health Syst Pharm. 2008 Jun 1;65(11):1039-47. doi: 10.2146/ajhp070284.

Analgesic nitrous oxide in alcohol withdrawal: the role of melatonin.

Int J Neurosci. 1991 Jan-Feb;56(1-4):201-5, 207-8. doi: 10.3109/00207459108985417.

Analgesic nitrous oxide for alcohol withdrawal is better than placebo.

Int J Neurosci. 1989 Nov;49(1-2):71-4. doi: 10.3109/00207458909087040.

引用本文的文献

Benzodiazepines for alcohol withdrawal.

Cochrane Database Syst Rev. 2010 Mar 17(3):CD005063. doi: 10.1002/14651858.CD005063.pub3.